Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral VK2735

A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities

Viking Therapeutics · Phase 1 · Recruiting · Enrollment 270

NCT07838740

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebon/rn/rn/rn/rn/r
VK2735 Dose Level 2n/rn/rn/rn/rn/r
VK2735 Dose Level 3n/rn/rn/rn/rn/r
VK2735 Dose Level 4n/rn/rn/rn/rn/r
VK2735 Dose Level 5n/rn/rn/rn/rn/r
VK2735 Dose Level 6n/rn/rn/rn/rn/r
VK2735 Dose Level 7n/rn/rn/rn/rn/r
VK2735 Dose Level 8n/rn/rn/rn/rn/r
VK2735 Dose Level 9n/rn/rn/rn/rn/r
VK2735 Dose Level 10n/rn/rn/rn/rn/r
VK2735 Dose Level 11n/rn/rn/rn/rn/r
VK2735 Dose Level 12n/rn/rn/rn/rn/r
VK2735 Dose Level 14n/rn/rn/rn/rn/r
VK2735 Dose Level 15n/rn/rn/rn/rn/r
VK2735 Dose Level 16n/rn/rn/rn/rn/r
VK2735 Dose Level 17n/rn/rn/rn/rn/r
VK2735 Dose Level 18n/rn/rn/rn/rn/r
VK2735 Dose Level 13n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.